Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches

Monoclonal antibody (mAb)-based therapies have experienced considerable growth in cancer management. When labeled with radionuclides, mAbs also represent promising probes for imaging or theranostic approaches. Initially, mAbs have been radiolabeled with single-photon emitters, such as 131I, 99mTc, o...

Full description

Bibliographic Details
Main Authors: Caroline Bodet-Milin, Clément Bailly, Yann Touchefeu, Eric Frampas, Mickael Bourgeois, Aurore Rauscher, Franck Lacoeuille, Delphine Drui, Nicolas Arlicot, David M. Goldenberg, Alain Faivre-Chauvet, Jacques Barbet, Caroline Rousseau, Françoise Kraeber-Bodéré
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Medicine
Subjects:
medullary thyroid carcinoma (MTC)
immunoPET
theranostic (therapeutic and diagnostic)
pretargeted imaging
radioimmunoconjugate
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00124/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2019.00124/full

Similar Items